OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The cell-line-derived subcutaneous tumor model in preclinical cancer research
Stephen M. Stribbling, Anderson J. Ryan
Nature Protocols (2022) Vol. 17, Iss. 9, pp. 2108-2128
Closed Access | Times Cited: 51
Stephen M. Stribbling, Anderson J. Ryan
Nature Protocols (2022) Vol. 17, Iss. 9, pp. 2108-2128
Closed Access | Times Cited: 51
Showing 26-50 of 51 citing articles:
Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
Mengping Chen, Jinxing Jiang, Jian Hou
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Mengping Chen, Jinxing Jiang, Jian Hou
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 10
A Comparative Analysis of Orthotopic and Subcutaneous Pancreatic Tumour Models: Tumour Microenvironment and Drug Delivery
Jessica Lage Fernandez, Sara Årbogen, Mohammad Sadeghinia, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5415-5415
Open Access | Times Cited: 9
Jessica Lage Fernandez, Sara Årbogen, Mohammad Sadeghinia, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5415-5415
Open Access | Times Cited: 9
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
Brian J. Thomas, Caitlyn Guldenpfennig, Yue Guan, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102046-102046
Open Access | Times Cited: 8
Brian J. Thomas, Caitlyn Guldenpfennig, Yue Guan, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102046-102046
Open Access | Times Cited: 8
Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics
Sulaiman Mohammed Alnasser
Stem Cells International (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 8
Sulaiman Mohammed Alnasser
Stem Cells International (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 8
Multiplexed In Vivo Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents
Brian J. Thomas, Caitlyn Guldenpfennig, Mark A. Daniëls, et al.
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 3, pp. 109-124
Closed Access | Times Cited: 2
Brian J. Thomas, Caitlyn Guldenpfennig, Mark A. Daniëls, et al.
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 3, pp. 109-124
Closed Access | Times Cited: 2
In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
Sanaz Pournajaf, Nastaran Afsordeh, Mohammad H. Pourgholami
Reviews in the Neurosciences (2023) Vol. 35, Iss. 2, pp. 183-195
Closed Access | Times Cited: 5
Sanaz Pournajaf, Nastaran Afsordeh, Mohammad H. Pourgholami
Reviews in the Neurosciences (2023) Vol. 35, Iss. 2, pp. 183-195
Closed Access | Times Cited: 5
Tumour induction in BALB /c mice for imaging studies: An improved protocol
Abolfazl Amini, Gholamreza Mesbah, Fatemeh T. Shamsabadi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1880-1886
Open Access | Times Cited: 4
Abolfazl Amini, Gholamreza Mesbah, Fatemeh T. Shamsabadi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1880-1886
Open Access | Times Cited: 4
Voluntary exercise does not always suppress lung cancer progression
Aurelia C. Leimbacher, Philipp Villiger, Nina Desboeufs, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107298-107298
Open Access | Times Cited: 4
Aurelia C. Leimbacher, Philipp Villiger, Nina Desboeufs, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107298-107298
Open Access | Times Cited: 4
Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
Yani Berckmans, Jolien Ceusters, Ann Vankerckhoven, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Yani Berckmans, Jolien Ceusters, Ann Vankerckhoven, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner
Qian-Lin Wang, Li Wang, Qiong-Yu Li, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 6, pp. 4447-4459
Closed Access | Times Cited: 4
Qian-Lin Wang, Li Wang, Qiong-Yu Li, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 6, pp. 4447-4459
Closed Access | Times Cited: 4
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures
Thomas J. Ow, Vikas Mehta, Dan Li, et al.
The Laryngoscope (2024) Vol. 134, Iss. 6, pp. 2748-2756
Closed Access | Times Cited: 1
Thomas J. Ow, Vikas Mehta, Dan Li, et al.
The Laryngoscope (2024) Vol. 134, Iss. 6, pp. 2748-2756
Closed Access | Times Cited: 1
Deletion of MyD88 in T Cells Improves Antitumor Activity in Melanoma
Abraham L. Bayer, Darwing Padilla-Rolon, Sasha Smolgovsky, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 1007-1019
Closed Access | Times Cited: 1
Abraham L. Bayer, Darwing Padilla-Rolon, Sasha Smolgovsky, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 6, pp. 1007-1019
Closed Access | Times Cited: 1
Yin and yang roles of B lymphocytes in solid tumors: Balance between antitumor immunity and immune tolerance/immunosuppression in tumor-draining lymph nodes
Tomoya Katakai
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Tomoya Katakai
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
The Dual-Targeted Peptide Conjugated Probe for Depicting Residual Nasopharyngeal Carcinoma and Guiding Surgery
Wenhui Huang, Zicong He, Xuekang Cai, et al.
Biosensors (2022) Vol. 12, Iss. 9, pp. 729-729
Open Access | Times Cited: 3
Wenhui Huang, Zicong He, Xuekang Cai, et al.
Biosensors (2022) Vol. 12, Iss. 9, pp. 729-729
Open Access | Times Cited: 3
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cell-Derived Allograft Models as a Solution to the Obstacles of Preclinical Studies under Limited Resources: A Systematic Review on Experimental Lung Cancer Animal Models
I Nyoman Bayu Mahendra, Ahmad Kurniawan, Muhamad Basit Febrian, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 20, Iss. 1, pp. 49-59
Closed Access
I Nyoman Bayu Mahendra, Ahmad Kurniawan, Muhamad Basit Febrian, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 20, Iss. 1, pp. 49-59
Closed Access
Increasing DNA damage sensitivity through corylin-mediated inhibition of homologous recombination
Yann-Lii Leu, Shu‐Fang Cheng, Tong‐Hong Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116864-116864
Open Access
Yann-Lii Leu, Shu‐Fang Cheng, Tong‐Hong Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116864-116864
Open Access
Evidence-Based Severity Assessment of Animal Models for Pancreatic Cancer
Tim Schreiber, Ingo Koopmann, Jakob Brandstetter, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1494-1494
Open Access
Tim Schreiber, Ingo Koopmann, Jakob Brandstetter, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1494-1494
Open Access
Staphylococcus aureus wraps around Candida albicans and synergistically escapes from Neutrophil extracellular traps
Jing Qi, Rui Liu, Qingsong Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jing Qi, Rui Liu, Qingsong Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Oncology Pharmacology
Jason H. Gill, Steven D. Shnyder
Springer eBooks (2024), pp. 825-859
Closed Access
Jason H. Gill, Steven D. Shnyder
Springer eBooks (2024), pp. 825-859
Closed Access
Broussoflavonol F exhibited anti-proliferative and anti-angiogenesis effects in colon cancer via modulation of the HER2-RAS-MEK-ERK pathway
Yiying Zhu, Xiaoli Li, Grace Gar‐Lee Yue, et al.
Phytomedicine (2024) Vol. 135, pp. 156243-156243
Closed Access
Yiying Zhu, Xiaoli Li, Grace Gar‐Lee Yue, et al.
Phytomedicine (2024) Vol. 135, pp. 156243-156243
Closed Access
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Brian J. Thomas, Sania Zafar Awan, Trupti Joshi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
Meirui Qian, Ziyu Wan, Xue Liang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Meirui Qian, Ziyu Wan, Xue Liang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Ultrasound-Targeted Microbubble Destruction Enhances the Inhibitory Effect of Sonodynamic Therapy against Hepatocellular Carcinoma
Huajing Yang, Yunfeng Qu, Yuhang Tian, et al.
ACS Omega (2024) Vol. 9, Iss. 52, pp. 51253-51263
Open Access
Huajing Yang, Yunfeng Qu, Yuhang Tian, et al.
ACS Omega (2024) Vol. 9, Iss. 52, pp. 51253-51263
Open Access
The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models
Martina Jabloñski, María Sol Rodríguez, Ezequiel Mariano Rivero, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 485-499
Closed Access | Times Cited: 1
Martina Jabloñski, María Sol Rodríguez, Ezequiel Mariano Rivero, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 6, pp. 485-499
Closed Access | Times Cited: 1
